Skip to content

Diabetes Medical Nutrition Therapy in Southeastern African American Women

Diabetes Medical Nutrition Therapy in Southeastern African American Women

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04971889
Enrollment
291
Registered
2021-07-22
Start date
2021-08-03
Completion date
2026-01-31
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.

Interventions

BEHAVIORALDiabetes MNT

Group-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake

BEHAVIORALMotivational Interviewing

Group-based support for dietary self-care motivation using culturally-adapted motivational interviewing exercise

Sponsors

Patient-Centered Outcomes Research Institute
CollaboratorOTHER
Matthew Walker Comprehensive Health Center
CollaboratorUNKNOWN
Vanderbilt University
CollaboratorOTHER
Meharry Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* African American * Female * Clinical diagnosis of type 2 diabetes for at least 6 months * At risk for development and/or progression of diabetes complications (HbA1c ≥ 7.0% AND either systolic blood pressure ≥130, LDL cholesterol ≥ 100, or BMI ≥ 30).

Exclusion criteria

--Observed or diagnosed psychotic disorders

Design outcomes

Primary

MeasureTime frameDescription
HbA1cBaselineWidely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Change from Baseline HbA1c3 monthsWidely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Secondary

MeasureTime frameDescription
Change from Baseline Body Mass Index3 monthsCalculated measure of body max index from height/weight measures
LDL CholesterolBaselineStandard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Systolic Blood PressureBaselineA sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Change from baseline Systolic Blood Pressure3 monthsA sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Change from baseline LDL Cholesterol3 monthsStandard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Body Mass IndexBaselineCalculated measure of body max index from height/weight measures

Other

MeasureTime frameDescription
Situational Obstacles to Dietary Adherence QuestionnaireBaselineUses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Carbohydrate Management Attitude ScaleBaselineUses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Change from baseline Situational Obstacles to Dietary Adherence Questionnaire3 monthsUses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Change from baseline Carbohydrate Management Attitude Scale3 monthsUses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Fat Management Attitude ScaleBaselineUses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Change from baseline Fat Management Attitude Scale3 monthsUses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Diabetes Empowerment ScaleBaselineUses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Change from baseline Diabetes Empowerment Scale3 monthsUses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Problem Areas in Diabetes Scale QuestionnaireBaselineUses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.
Change from baseline Problem Areas in Diabetes Scale Questionnaire3 monthsUses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026